Table of Contents Table of Contents
Previous Page  84 / 123 Next Page
Information
Show Menu
Previous Page 84 / 123 Next Page
Page Background

Collaborative Study Report: Method 2011.20 Nucleotides by HPLC-UV

Page 19

Method Accuracy

Method accuracy was assessed in accordance with SPIFAN procedures based on results of the NIST1869a

samples tested as part of the final study sample sets (Table 3). The

p

-value of 0.32 indicates no bias was

found against the certified value (5). Placebo samples not fortified with vitamin D returned negligible results

for vitamin D as expected.

Table 3: Accuracy results for vitamin D in NIST1849a CRM

FORTIFIED: NIST1849a CRM KGSZ273/LTCT316

Seq.

Bias

Analyte

Vitamin D3

Symbol

Value

1

Overall mean of all data (grand mean)

x

10.2

µg hg

-1

2

Total number of replicates

Sum(n(L))

36

2

Certified value (ug/hg)

µ

11.1 µg hg

-1

3

Uncertainty

U

CRV

1.7 µg hg

-1

4

Coverage factor

k

2.0

5

Students's test-statistic

t

STAT

1.0

6

Degrees of freedom

DF

63.0

7

p-value

0.32

Method Applicability

The Vitamin D SMPR applicability statement:

Determination of total vitamin D

2

and vitamin D

3

in all forms (powders, ready-to-feed liquids, and liquid

concentrates) of infant, adult, and pediatric nutritional formulas. For the purpose of this SMPR, vitamin D2 is

defined as ergocalciferol (CAS 8017-28-5) and its previtamin isomer; and vitamin D3 is defined as

cholecalciferol (CAS 67-97-0) and its previtamin isomer

(3)

The method has been demonstrated to be suitable for the analysis of vitamin D in a wide range of infant

formulas and nutritional products, as illustrated with the range of different matrices used in this collaborative

study.

Safety Considerations

There are no major hazards beyond those typically found in chemistry laboratories. Use appropriate safety

equipment when handling acids, bases, and solvents. Refer to MSD sheets for detailed safety instructions

for each chemical used.

Comments from Collaborators

A summary of each laboratory’s performance was sent to participants along with an invitation to make

comments on the performance of the method in their laboratory. The following comments were received:

2016.05 (FEBRUARY 2017) VITD-18

MLT REPORT

FOR ERP USE ONLY

DO NOT DISTRIBUTE